1. Home
  2. QTRX vs HCAT Comparison

QTRX vs HCAT Comparison

Compare QTRX & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTRX
  • HCAT
  • Stock Information
  • Founded
  • QTRX 2007
  • HCAT 2008
  • Country
  • QTRX United States
  • HCAT United States
  • Employees
  • QTRX N/A
  • HCAT N/A
  • Industry
  • QTRX Biotechnology: Laboratory Analytical Instruments
  • HCAT Computer Software: Programming Data Processing
  • Sector
  • QTRX Industrials
  • HCAT Technology
  • Exchange
  • QTRX Nasdaq
  • HCAT Nasdaq
  • Market Cap
  • QTRX 233.5M
  • HCAT 259.8M
  • IPO Year
  • QTRX 2017
  • HCAT 2019
  • Fundamental
  • Price
  • QTRX $5.85
  • HCAT $3.88
  • Analyst Decision
  • QTRX Buy
  • HCAT Buy
  • Analyst Count
  • QTRX 4
  • HCAT 11
  • Target Price
  • QTRX $13.50
  • HCAT $8.00
  • AVG Volume (30 Days)
  • QTRX 691.9K
  • HCAT 552.2K
  • Earning Date
  • QTRX 08-07-2025
  • HCAT 08-07-2025
  • Dividend Yield
  • QTRX N/A
  • HCAT N/A
  • EPS Growth
  • QTRX N/A
  • HCAT N/A
  • EPS
  • QTRX N/A
  • HCAT N/A
  • Revenue
  • QTRX $135,688,000.00
  • HCAT $311,274,000.00
  • Revenue This Year
  • QTRX N/A
  • HCAT $11.11
  • Revenue Next Year
  • QTRX $14.28
  • HCAT $9.27
  • P/E Ratio
  • QTRX N/A
  • HCAT N/A
  • Revenue Growth
  • QTRX 7.71
  • HCAT 4.88
  • 52 Week Low
  • QTRX $4.05
  • HCAT $3.49
  • 52 Week High
  • QTRX $16.01
  • HCAT $9.24
  • Technical
  • Relative Strength Index (RSI)
  • QTRX 50.18
  • HCAT 49.89
  • Support Level
  • QTRX $5.09
  • HCAT $3.61
  • Resistance Level
  • QTRX $5.84
  • HCAT $4.08
  • Average True Range (ATR)
  • QTRX 0.38
  • HCAT 0.17
  • MACD
  • QTRX -0.05
  • HCAT 0.01
  • Stochastic Oscillator
  • QTRX 48.41
  • HCAT 52.94

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Share on Social Networks: